×
App Icon
The Standard e-Paper
Join Thousands Daily
★★★★ - on Play Store
Download App

Ebola research takes time, resources

Since the first outbreak of Ebola in 1976, the global pharmaceutical industry has invested little in Ebola research. All previous outbreaks have been sporadic, self-limiting and have occurred in poor populations – generating little, if any, commercial appeal for developing treatments. That is now changing.

The current outbreak, which is the worst on record and responsible for at least 4,500 deaths, is generating unprecedented interest among pharmaceutical companies and research institutions.

Get Full Access for Ksh299/Week.
Fact‑first reporting that puts you at the heart of the newsroom. Subscribe for full access.
  • Unlimited access to all premium content
  • Uninterrupted ad-free browsing experience
  • Mobile-optimized reading experience
  • Weekly Newsletters
  • MPesa, Airtel Money and Cards accepted
Already a subscriber? Log in

Related Topics

Ebola